维普期刊资源整合服务平台（V6.5）

70篇 您的检索式：作者名="CALVERLEY P M"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised,placebo-controlled TORCH study 显示文摘	Jenkins C R Jones P W Calverley P M	2009	Respir Res2009，10，：	1
2	Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease 显示文摘	CALVERLEY P M SANCHEZ TORIL F MCIVOR A	2007	Am J Respir Crit Care Med2007，176，2：	1
3	Salmeterol and fiutica- sone propionate and survival in chronic obstructive pulmonary disease显示文摘	Calverley P M Anderson J A Celli B	2007	N Engl J Med2007，356，8：	1
4	The prevention of chronic obstructive pulmonary disease exacerba- tions by salmeterol/flution - casone propionate or tiltopium bromide显示文摘	Wedzicha J A Calverley P M Seemungal T A	2008	Am J Respir Crit Care Med2008，177，：	1
5	Reducing the frequency and severity of excerbationsof chronic obstructive pulmonary disease显示文摘	Calverley P M A	2004	Proc Am Thorac Soc2004，1，：	1
6	Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease显示文摘	Pauwels R A Buist A S Calverley P M A	2012	American journal of respiratory and critical care medicine2012，163，5：	1
7	Impact of preventing exacerbations on deterioration of health status in COPD 显示文摘	Spencer S Calverley P M Burge P S	2004	Eur Respir J2004，23，5：	1
8	Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease 显示文摘	Calverley P M Anderson J A Celli B	2007	N Engl J Med2007，356，8：	1
9	Simultaneous tracheal and oesophageal pH measurement in asthmatic patients with gastroesophageal reflux显示文摘	Jack C I Calverley P M Donnelly R J	1995	Thorax1995，50，2：	1
10	Chronic obstructive pulmonary disease phenotypes:the future of COPD显示文摘	Han MLK Agusti A Calverley P M	2010	American journal of respiratory and critical care medicine2010，182，5：	1
11	Long-acting inhaledanticholinergic therapy improves sleeping oxygen saturation in COPD显示文摘	McNicholas W T Calverley P M Lee A	2004	Eur Respir J2004，23，6：	1
12	Chronic obstructivepulmonary disease phenotypes:the future of COPD显示文摘	Han M K Agusti A Calverley P M	2010	Am J Re-spir Crit Care Med2010，182，5：	1
13	Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease显示文摘	Calverley P M Anderson J A Celli B	2007	N Engl J Med2007，356，8：	1
14	Sahnetcrol and fluticasone propionate and survival in chronic obstructive pulmonary disease显示文摘	Calverley P M Anderson J A Celli B	2007	N EnglJ Med2007，356，8：	1
15	Chronic obstructive pulmonary disease phenotypes:the future of COPD显示文摘	Han M K Agusti A Calverley P M	2010	Am J Respir Crit Care Med2010，182，5：	1
16	Chronic obstructive pulmonary disease phenotypes:the future of COPD显示文摘	HAN M K AGUSTI A CALVERLEY P M	2010	Am J Respir Crit Care Med2010，182，5：	1
17	Maintenance therapy in chronic obstructive pulmonary disease显示文摘	Calverley P M Boonsawat W Cseke Z	2003	Eur Respir J2003，22，6：	1
18	The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide显示文摘	Wedzicha J A Calverley P M Seemungal T A	2008	Am JK Respir Crit Care Med2008，177，：	1
19	Oral corticosteroids in patients admitted to hospital with AECOPD:a prospestive randomized controlled trial显示文摘	Davies L Angus R M Calverley P M	1999	Lancet1999，354，：	1
20	Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease显示文摘	Calverley P M Anderson J A Celli B	2007	N Engl J Med2007，356，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示